Highlander Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25
| Closed | -$690 | – | 960 |
|
|
2023
Q4 | $690 | Hold |
25
| – | – | ﹤0.01% | 923 |
|
|
2023
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 831 |
|
|
2023
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 634 |
|
|
2023
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 620 |
|
|
2022
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 578 |
|
|
2022
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 559 |
|
|
2022
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 587 |
|
|
2022
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 571 |
|
|
2021
Q4 | $5K | Sell |
25
-106
| -81% | -$25K | ﹤0.01% | 516 |
|
|
2021
Q3 | $32K | Hold |
131
| – | – | 0.02% | 333 |
|
|
2021
Q2 | $54K | Sell |
131
-31
| -19% | -$12.3K | 0.03% | 284 |
|
|
2021
Q1 | $63K | Buy |
162
+46
| +40% | +$22.7K | 0.03% | 258 |
|
|
2020
Q4 | $65K | Sell |
116
-54
| -32% | -$34.2K | 0.04% | 247 |
|
|
2020
Q3 | $119K | Buy |
170
+54
| +47% | +$42.1K | 0.07% | 185 |
|
|
2020
Q2 | $92K | Hold |
116
| – | – | 0.06% | 206 |
|
|
2020
Q1 | $69K | Sell |
116
-31
| -21% | -$30.2K | 0.05% | 236 |
|
|
2019
Q4 | $167K | Buy |
147
+31
| +27% | +$33.7K | 0.1% | 165 |
|
|
2019
Q3 | $138K | Hold |
116
| – | – | 0.09% | 190 |
|
|
2019
Q2 | $191K | Sell |
116
-23
| -17% | -$39.8K | 0.12% | 160 |
|
|
2019
Q1 | $283K | Buy |
139
+23
| +20% | +$40.5K | 0.18% | 121 |
|
|
2018
Q4 | $149K | Hold |
116
| – | – | 0.1% | 188 |
|
|
2018
Q3 | $219K | Hold |
116
| – | – | 0.12% | 163 |
|
|
2018
Q2 | $235K | Hold |
116
| – | – | 0.13% | 156 |
|
|
2018
Q1 | $256K | Hold |
116
| – | – | 0.15% | 147 |
|
|
2017
Q4 | $267K | Hold |
116
| – | – | 0.2% | 129 |
|
|
2017
Q3 | $206K | Hold |
116
| – | – | 0.16% | 156 |
|
|
2017
Q2 | $158K | Hold |
116
| – | – | 0.12% | 188 |
|
|
2017
Q1 | $136K | Hold |
116
| – | – | 0.11% | 203 |
|
|
2016
Q4 | $93K | Hold |
116
| – | – | 0.08% | 251 |
|
|
2016
Q3 | $102K | Hold |
116
| – | – | 0.09% | 235 |
|
|
2016
Q2 | $65K | Hold |
116
| – | – | 0.06% | 310 |
|
|
2016
Q1 | $64K | Hold |
116
| – | – | 0.06% | 307 |
|
|
2015
Q4 | $96K | Buy |
116
+39
| +51% | +$39K | 0.09% | 248 |
|
|
2015
Q3 | $85K | Hold |
77
| – | – | 0.08% | 266 |
|
|
2015
Q2 | $168K | Hold |
77
| – | – | 0.15% | 168 |
|
|
2015
Q1 | $121K | Hold |
77
| – | – | 0.1% | 223 |
|
|
2014
Q4 | $92K | Hold |
77
| – | – | 0.08% | 265 |
|
|
2014
Q3 | $35.9K | Buy |
+77
| New | +$35.5K | 0.03% | 411 |
|
Other funds holding BLUE
GIM
PAI
TCM
Highlander Capital Management's BLUE Position: Q1 2024 in Review
Highlander Capital Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 25 shares — an estimated $690 sold.
Highlander Capital Management first reported a position in BLUE in Q3 2014 and held it in 38 quarters. The position peaked at $283K in Q1 2019. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Highlander Capital Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Highlander Capital Management sold 25 bluebird bio shares in Q1 2024, an estimated $690.
- Highlander Capital Management first reported a position in bluebird bio in Q3 2014 and held it in 38 quarters.
- Highlander Capital Management's bluebird bio position peaked at $283K in Q1 2019.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.